-The Hindu Majority of patients are utilising public health facilities in the State for chronic disease treatment An evaluation has ranked Tamil Nadu at the top for implementation outcomes of the National Rural Health Mission (NRHM) and described it as a benchmark for other States. Analysis of data also reveals that in physical infrastructure per 1 lakh population with respect to Primary Health Centres, Community Health Centres, and First Reference Units, Jammu and...

-Live Mint Court says legal, ethical issues involved; directs govt to monitor and regulate clinical trials of all experimental drugs  The Supreme Court directed the health ministry to monitor and regulate all clinical trials of experimental drugs in the country until further notice and observed that unregulated trials have caused “havoc”. The apex court order on Thursday revoked the power of the Central Drugs Standard Control Organization under the Drugs Controller General of...

-Deccan Herald The Supreme Court said Thursday that unregulated clinical trials of new drugs were causing "havoc" in the country as it ordered the health ministry to monitor any new applications for tests. The comments were made during a hearing on a petition detailing deaths and health problems caused by clinical trials carried out on Indians, often without their knowledge or consent. "Uncontrolled clinical trials are causing havoc to human life," Justice RM...

-The Indian Express Lamenting the virtual collapse of public health system in major parts of the country, Union Minister Jairam Ramesh today said rural families are falling into debt trap due to expensive private health sector. In large parts of the country, particularly in central and eastern India and in tribal belts, he said public health system is "not abysmal but has collapsed". "Indebtedness caused by private health sector is one of the...

-The Economic Times The Union Cabinet has okayed a new price-control formula for pharmaceuticals, which seeks to cap prices at the arithmetic average of all drugs with more than 1% market share in any therapeutic segment that is to be brought under price control. Given that the existing system of fixing prices of select drugs is on the basis of costs, which is rigid, intrusive and prone to manipulation as well,...